Initiating Concerta(TM) (OROS® methylphenidate HCl) qd in children with attention-deficit hyperactivity disorder

Journal of Clinical Research

Volumn 3, Issue 59-76, 2000, Pages 59-76

  Swanson, J ^a   Greenhill, L ^a   Pelham, W ^a   Wilens, T ^a   Wolraich, M ^a   Abikoff, H ^a   Atkins, M ^a   August, G ^a   Biederman, J ^a   Bukstein, O ^a   Conners, C K ^a   Efron, L ^a   Fiebelkorn, K ^a   Fried, J ^a   Hoffman, M ^a   Lambrecht, L ^a   Lerner, M ^a   Leventhal, B ^a   McBurnett, K ^a   Morse, E ^a   Palumbo, D ^a   Pfiffner, L ^a   Stein, M ^a   Wigal, S ^a   Winans, E ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ADHD; Attention deficit hyperactivity disorder; Concerta(TM); Methylphenidate; OROS

Indexed keywords

METHYLPHENIDATE;

ABDOMINAL PAIN; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; CHILD BEHAVIOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TREATMENT OUTCOME;

EID: 0033850239     PISSN: 13695207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Psychiatric status of hyperactives as adults: A controlled prospective 15-year follow-up of 63 hyperactive children
2. Adult psychiatric status of hyperactive boys grown up
3. Attention-deficit hyperactivity disorder: The stimulants
4. Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity
5. How do hyperactive children feel about taking stimulants and will they tell the doctor?
6. Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate
7. Sustained release and standard methylphenidate effects on cognitive and social behavior in children with attention deficit disorder
8. Pemoline pharmacokinetics and long term therapy in children and attention deficit disorder and hyperactivity
9. Blood levels and tolerance to stimulants in ADHD children
10. Pharmacodynamics of pemoline in attention deficit disorder with hyperactivity
11. Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: A comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline
12. Pemoline effects on children with ADHD: A time-response by dose-response analysis on classroom measures
13. Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children
14. Single and multiple dose pharmacokinetics of an oral, once-a-day, osmotic, controlled-release OROS® (methylphenidate HCl) formulation
15. Once-a-day Concerta(TM) (methylphenidate HCI) extended-release tablets versus tid methylphenidate in a laboratory setting
16. Comparison of the efficacy and safety of OROS® methylphenidate HCl with methylphenidate tid and placebo in children with ADHD
17. Once-a-day Concerta(TM) (methylphenidate HCl) extended-release tablets versus methylphenidate in natural settings: Safety and efficacy
18. Randomized controlled trial of OROS® methylphenidate dosed qd in children with attention deficit/hyperactivity disorder
19. Evaluation of efficacy and safety of OROS® methylphenidate HCl (MPH) extended release tablets, methylphenidate tid, and placebo in children with ADHD
20. Predicting methylphenidate response in children with ADHD: Theoretical, empirical, and conceptual models
21. The NIMH Diagnostic Interview Schedule for Children Version 2.3 (DISC-2.3): Description, acceptability, prevalence rates, and performance in the MECA Study. Methods for the Epidemiology of Child and Adolescent Mental Disorders Study
22. Hyperactivity, inattention, and aggression in clinical practice
23. A children's global assessment scale (CGAS)
24. Normative data on the IOWA Conners Teacher Rating Scale
25. Long-term ADHD treatment with OROS® methylphenidate